Atlas of Genetics and Cytogenetics

in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS

Gene Section Review

LIMK1 (LIM domain 1) Ratna Chakrabarti Department of Molecular biology and Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, 12722 Research Parkway, Orlando, Florida 32826, USA (RC) Published in Atlas Database: August 2009 Online updated version : http://AtlasGeneticsOncology.org/Genes/LIMK1ID41159ch7q11.html DOI: 10.4267/2042/44796 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology

Identity Transcription The transcript contains 16 exons spanning a length of Other names: EC 2.7.11.1; LIMK; LIMK-1 3.332 kb. The mRNA contains a short 5'UTR but a HGNC (Hugo): LIMK1 long 3' end UTR. Two LIM domains, LIM1 and LIM2 Location: 7q11.23 are encoded by the exons 2-4. A single PDZ domain is encoded by the exons 2-6. A C-terminal domain is Local order: ELN, LIMK1, EIF4H, LAT2. encoded by exons 8-16.

Pseudogene None identified.

LIMK1 gene is located at chromosome 7 on the long arm Description (q11.23). The LIMK1 protein is composed of 647 amino acids. It DNA/RNA belongs to a unique family of LIM domain containing dual specificity (serine threonine and tyrosine) protein Description kinase. LIMK1 also has a PDZ domain in the middle of The gene starts at 73136092 bp from pter and ends at the gene and a kinase domain at the C-terminal end. A 73174790 bp from pter. Its size is 38699 bases and its stretch of basic amino acids resembling nuclear orientation lie in the plus strand. The 5' promoter localisation signal is present in the kinase domain and region (1.5 kb) contains putative sites for two nuclear export signal sequences containing transcriptional regulation including Sp1, MZF1, AP1 hydrophobic residues are present in the PDZ domain. and NF-E2. No consensus TATA box is evident.

A) LIMK1 gene consists of 16 exons. Exons 2-4 encode two LIM domains in tandem. Exons 4-6 encode a PDZ domain and exons 8-16 encode a serine/threonine kinase domain. B) A splice variant of LIMK1 (dLIMK1), which lacks the kinase domain. In this variant, intron 7 was extended to 61 additional bases at the 5' end of exon 8, which caused a frameshift in the LIMK1 ORF and resulted in premature termination after 12 missense mutations in dLIMK1.

Atlas Genet Cytogenet Oncol Haematol. 2010; 14(7) 641 LIMK1 (LIM domain kinase 1) Chakrabarti R

LIMK1 consists of specific domains, nuclear localisation signal (NLS) and nuclear exit signals (NES).

Expression Williams Syndrome exhibit impaired visuospatial constructive cognition possibly because of loss of LIMK1 exhibits tissue specific expression. It is LIMK1 gene. predominantly expressed in brain but to a moderate SNP: A single nucleotide polymorphism of LIMK1 in a extent in the heart and skeletal muscle. The least haplotype spanning Elastin gene has been linked to amount of LIMK1 expression was noted in the liver. susceptibility of intracranial aneurysm (IA). LIMK1 is also expressed in lesser amounts in various human epithelial cell lines and haematopoetic cell lines. Implicated in Localisation LIMK1 is primarily localized in the cytoplasm but also Prostate cancer transported to the nucleus. In the cytoplasm, LIMK1 is Disease colocalized with microtubules, and at the focal Prostate cancer is the most prevalent malignancy adhesion, stress fiber and at the lamellipodia. In the second to lung cancer in men in the western world. mitotic cells, LIMK1 is localized to the centrosomes Although slow growing, a subpopulation of prostate until early telophase and to the cleavage furrow during cancer patients develops highly invasive metastatic late telophase. disease that is nonresponsive to anti-androgen therapy Function and is usually fatal. LIMK1 regulates organization of actin cytoskeleton Prognosis through inactivating phosphorylation of the actin The gold standard for diagnosis of prostate cancer are depolymerizing family (ADF) protein cofilin. LIMK1 the Gleason scores and the serum PSA level. PSA level phosphorylates cofilin at Serine, which inhibits actin is also used for prognostic purposes. LIMK1 expression depolymerization and results in accumulation of F may have prognostic value for identification of actin. LIMK1 also regulates microtubule stability and metastatic progression as overexpression of LIMK1 has assembly through phosphorylation of p25/TPPP been noted in metastatic prostate cancer cells. (tubulin polymerization protein), which destabilizes Cytogenetics microtubules. Activated LIMK1 associates with Through cytogenetics method such as CGH and FISH gamma-tubulin at the centrosome during mitotic analysis chromosomal gain in 7q11.2 region or entire phases. LIMK1 is a multifunctional protein and is chromosome 7 including 7q11.23 locus has been involved in regulation of cell motility, cell cycle, reported in some prostate cancer cases. cytokinesis and cellular morphology. LIMK1 also Oncogenesis regulates neurite growth, synaptic stability, growth LIMK1 is overexpressed in prostate cancer cells and cone motility, axon formation through modulation of tissues compared to benign prostatic hyperplasia. Golgi dynamics and neuronal differentiation. Because LIMK1 plays an important role in mitosis, Homology microtubule dynamics and cytokinesis altered LIMK1 has 50% identity overall and 70% identity in expession of LIMK1 may cause mitotic defects. the kinase domain with another family member Aberrant expression of LIMK1 is also involved in LIMK2. Although both phosphorylate cofilin induction of invasion in prostate cancer cells. and regulate actin cytosketon reorganization current Breast cancer studies showed that LIMK2 has also different cellular Disease function. Breast cancer is one of the major cancers affecting women in the western world after skin cancer and Mutations second leading cause of cancer death in women. About Germinal 20% of breast cancers are familial and about 10% of breast cancer is because of inheritence of a mutated Hemizygous deletion of LIMK1 along with Elastin gene. Although the cure rate has been increased gene in a 1.5 MB deletion has been noted in patients because of the improved diagnostic approaches and with Williams-Beuren syndrome. Patients with

Atlas Genet Cytogenet Oncol Haematol. 2010; 14(7) 642 LIMK1 (LIM domain kinase 1) Chakrabarti R

early detection, the metastatic disease actually has been Alzheimer's pathology. Altered structures of axons and increased since 1990. dendrites, deposition of amyloid plaques leading to Prognosis neurofibrillary tangle formation in AD pathology are Overexpression of Her2/neu oncogene product is responsible for dementia and cognitive disorder in considered to be associated with worse prognosis. Alzheimer's patients. LIMK1 expression may have a prognostic value for Prognosis metastatic breast cancer as overexpression of LIMK1 Deposition of fibrillar amyloid beta in the brain is one has been noted in metastatic breast cancer cells. of the events towards developing Alzheimer Disease. Cytogenetics LIMK1 has been shown to be involved in amyloid CGH analysis indicated a gain in chromosome 7 in beta-induced neuronal degeneration. majority of the infiltrating ductal carcinoma cases. Immunofluorescence analysis showed an increased Some of the chromosomal gains include the region number of phosphorylated LIMK1 positive neurons in encompassing Elastin and LIMK1 loci. the areas of brain with AD pathology. Inhibition of cofilin phosphorylation prevented neuronal Oncogenesis degeneration, which supports the involvement of Overexpression of LIMK1 has been shown to increase LIMK1 in AD. invasion and metastasis in animals. LIMK1 also involved in regulation of EGFR turnover through Intracranial Aneurysm endocytic pathway in invasive breast cancer cells, Disease which may have implication in development of an Intracranial aneurysm is the localized dilation of the agressive disease. blood vessel which could be fatal upon rupture causing Melanoma hemorrhage in the subarachnoid space. It occurs more frequently in adults than children and in women than Disease men. Risk factors include family history of aneurysm Malignant melanoma is an agressive type of skin and inherited disorders including polycystic kidney cancer, which often metastasize leading to death. The disease. progression of melanoma is unpredictable and sometimes show refractoriness to available Cytogenetics chemotherapy. Genome wide linkage studies indicated a significant association between SNP in LIMK1 promoter sequence Cytogenetics at 7q11.2 locus and incidence of IA in Japanese and Chromosomal analysis using tiling array and CGH Korean patients. The SNP in the promoter sequence of showed a gain in chromosome 7 in melanoma cells. LIMK1 [C(-187)T] introduced an additional Increased expression of LIMK1 in melanoma cells transcription factor (AP2) , which leads to a (Skmel 28) harboring a break at 7q11.2 has also been reduced transcription of LIMK1 mRNA. reported. Williams-beuren syndrome (WBS) References Disease Mizuno K, Okano I, Ohashi K, Nunoue K, Kuma K, Miyata T, WBS is a genetic disorder with autosomal dominant Nakamura T. Identification of a human cDNA encoding a novel inheritence. WBS is caused by microdeletion at with two repeats of the LIM/double finger 7q11.23 region with a phenotype of connective tissue motif. Oncogene. 1994 Jun;9(6):1605-12 abnormalities, growth and psychomotor retardation, Tassabehji M, Metcalfe K, Fergusson WD, Carette MJ, Dore muscular hypotonia, loss of visuospatial cognition and JK, Donnai D, Read AP, Pröschel C, Gutowski NJ, Mao X, Sheer D. LIM-kinase deleted in Williams syndrome. Nat Genet. behavioural abnormalities. 1996 Jul;13(3):272-3 Prognosis Higuchi O, Amano T, Yang N, Mizuno K. Inhibition of activated The presence of supravalvular aortic stenosis, Ras-induced neuronal differentiation of PC12 cells by the LIM pulmonary stenosis, developmental retardation and domain of LIM-kinase 1. Oncogene. 1997 Apr 17;14(15):1819- characteristic facial features in children between 18 to 25 30 months. Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffitt J, Wilber K, Lieber MM, Liu W, Smith DI. A Cytogenetics molecular cytogenetic analysis of 7q31 in prostate cancer. Chromosome analyses showed a deletion at the LIMK1 Cancer Res. 1998 Feb 15;58(4):759-66 locus at 7q11.23 caused by a distal recombination event Edwards DC, Gill GN. Structural features of LIM kinase that at the common telomeric breakpoint. control effects on the actin cytoskeleton. J Biol Chem. 1999 Alzheimer disease (AD) Apr 16;274(16):11352-61 Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Disease Rosenberg C, Tanke HJ, Schröder FH, van Dekken H. Dystrophic neurites are found to be associated with Identification of genetic markers for prostatic cancer progression. Lab Invest. 2000 Jun;80(6):931-42

Atlas Genet Cytogenet Oncol Haematol. 2010; 14(7) 643 LIMK1 (LIM domain kinase 1) Chakrabarti R

Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase 1 is Kimm K, Inoue I. A haplotype spanning two genes, ELN and essential for the invasive growth of prostate epithelial cells: LIMK1, decreases their transcripts and confers susceptibility to implications in prostate cancer. J Biol Chem. 2003 Sep intracranial aneurysms. Hum Mol Genet. 2006 May 19;278(38):36868-75 15;15(10):1722-34 Endo M, Ohashi K, Sasaki Y, Goshima Y, Niwa R, Uemura T, Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R. LIM Mizuno K. Control of growth cone motility and morphology by kinase 1 increases tumor metastasis of human breast cancer LIM kinase and Slingshot via phosphorylation and cells via regulation of the urokinase-type plasminogen activator dephosphorylation of cofilin. J Neurosci. 2003 Apr system. Int J Cancer. 2006 Jun 1;118(11):2703-10 1;23(7):2527-37 Heredia L, Helguera P, de Olmos S, Kedikian G, Solá Vigo F, Yoshioka K, Foletta V, Bernard O, Itoh K. A role for LIM kinase LaFerla F, Staufenbiel M, de Olmos J, Busciglio J, Cáceres A, in cancer invasion. Proc Natl Acad Sci U S A. 2003 Jun Lorenzo A. Phosphorylation of actin-depolymerizing 10;100(12):7247-52 factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Rosso S, Bollati F, Bisbal M, Peretti D, Sumi T, Nakamura T, Alzheimer's disease. J Neurosci. 2006 Jun 14;26(24):6533-42 Quiroga S, Ferreira A, Cáceres A. LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process Nishimura Y, Yoshioka K, Bernard O, Bereczky B, Itoh K. A extension in primary cultured neurons. Mol Biol Cell. 2004 role of LIM kinase 1/cofilin pathway in regulating endocytic Jul;15(7):3433-49 trafficking of EGF receptor in human breast cancer cells. Histochem Cell Biol. 2006 Nov;126(5):627-38 Eaton BA, Davis GW. LIM Kinase1 controls synaptic stability downstream of the type II BMP receptor. Neuron. 2005 Sep Chakrabarti R, Jones JL, Oelschlager DK, Tapia T, Tousson A, 1;47(5):695-708 Grizzle WE. Phosphorylated LIM colocalize with gamma-tubulin in centrosomes during early stages of mitosis. Gorovoy M, Niu J, Bernard O, Profirovic J, Minshall R, Neamu Cell Cycle. 2007 Dec 1;6(23):2944-52 R, Voyno-Yasenetskaya T. LIM kinase 1 coordinates microtubule stability and actin polymerization in human Jönsson G, Dahl C, Staaf J, Sandberg T, Bendahl PO, Ringnér endothelial cells. J Biol Chem. 2005 Jul 15;280(28):26533-42 M, Guldberg P, Borg A. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene. 2007 Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C, Jul 12;26(32):4738-48 Haas OA, Wolff K, Pehamberger H. Seven novel and stable translocations associated with oncogenic gene expression in This article should be referenced as such: malignant melanoma. Neoplasia. 2005 Apr;7(4):303-11 Chakrabarti R. LIMK1 (LIM domain kinase 1). Atlas Genet Akagawa H, Tajima A, Sakamoto Y, Krischek B, Yoneyama T, Cytogenet Oncol Haematol. 2010; 14(7):641-644. Kasuya H, Onda H, Hori T, Kubota M, Machida T, Saeki N, Hata A, Hashiguchi K, Kimura E, Kim CJ, Yang TK, Lee JY,

Atlas Genet Cytogenet Oncol Haematol. 2010; 14(7) 644